These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 6322974)

  • 1. Schizophyllan (SPG)-treated macrophages and anti-tumor activities against syngeneic and allogeneic tumor cells. I. Characteristics of SPG-treated macrophages.
    Sugawara I; Lee KC; Wong M
    Cancer Immunol Immunother; 1984; 16(3):137-44. PubMed ID: 6322974
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cytokine-related immunomodulating activities of an anti-tumor glucan, sizofiran (SPG).
    Tsuchiya Y; Igarashi M; Inoue M; Kumagai K
    J Pharmacobiodyn; 1989 Oct; 12(10):616-25. PubMed ID: 2534316
    [TBL] [Abstract][Full Text] [Related]  

  • 3. In vitro activation of human adherent cells by a glucan, Schizophyllan.
    Mashiba H; Matsunaga K
    Jpn J Exp Med; 1983 Aug; 53(4):195-8. PubMed ID: 6229661
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A novel rat monoclonal antibody directed against a population of activated mouse peritoneal macrophages.
    Someya A
    Microbiol Immunol; 1986; 30(6):573-88. PubMed ID: 3747866
    [TBL] [Abstract][Full Text] [Related]  

  • 5. In vitro cytotoxicity of peritoneal macrophages activated with Mycobacterium smegmatis.
    Yamamoto S; Tokunaga T
    Microbiol Immunol; 1978; 22(1):27-40. PubMed ID: 661626
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Antitumor activity of schizophyllan (SPG) against syngeneic ACI/N rat tumor, AMC-60 fibrosarcoma and BC-47 bladder cancer].
    Mitani M; Arika T; Matsuo T; Asano T
    Gan To Kagaku Ryoho; 1984 Sep; 11(9):1809-17. PubMed ID: 6236752
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inhibition of pulmonary metastasis of Lewis lung carcinoma by a glucan, Schizophyllan.
    Yamamoto T; Yamashita T; Tsubura E
    Invasion Metastasis; 1981; 1(1):71-84. PubMed ID: 6234252
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Immunotherapy of malignant lymphoma with interleukin-2 and sizofiran--a basic study on EL-4 lymphoma-transplanted mice].
    Hashimoto J
    Nihon Jibiinkoka Gakkai Kaiho; 1994 Jul; 97(7):1235-49. PubMed ID: 8064508
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cooperative role of T lymphocytes and macrophages in anti-tumor activity of mice pretreated with schizophyllan (SPG).
    Suzuki M; Arika T; Amemiya K; Fujiwara M
    Jpn J Exp Med; 1982 Apr; 52(2):59-65. PubMed ID: 6214649
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The role of host lymphocytes and host macrophages in antitumor reactions after injection of sensitized lymphocytes and tumor target cells into naive mice.
    Dullens HF; Vuist W; Van der Maas M; Den Otter W
    Cancer Immunol Immunother; 1986; 23(2):113-8. PubMed ID: 3536093
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Macrophage tumoricidal activity as a possible antitumor mechanism associated with the local injection of allogeneic spleen cells into rats.
    Kawase I; Komuta K; Namba M; Yokota S; Ogura T; Kishimoto S
    Cancer Res; 1986 Mar; 46(3):1047-54. PubMed ID: 3510719
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Immunoregulatory and antitumor activity of schizophyllan under ultrasonic treatment.
    Zhong K; Tong L; Liu L; Zhou X; Liu X; Zhang Q; Zhou S
    Int J Biol Macromol; 2015 Sep; 80():302-8. PubMed ID: 26126943
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Role of the murine major histocompatibility complex in macrophage-mediated cytolysis.
    Somers SD; Zwilling BS
    J Immunol; 1978 Dec; 121(6):2453-7. PubMed ID: 214499
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Specific tumoricidal activity of cytotoxic macrophages and cytotoxic lymphocytes.
    Dullens HF; Schakenraad S; Oostdijk A; Vuist W; Van der Maas M; Den Otter W
    Cancer Immunol Immunother; 1986; 22(2):100-6. PubMed ID: 3487380
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Rejection of syngeneic tumor cells by the interaction of Lyt-1+ T lymphocytes and macrophages.
    Mitani M; Matsumoto T; Mori K; Miake S; Himeno K; Nomoto K
    J Clin Lab Immunol; 1985 Oct; 18(2):97-101. PubMed ID: 3935795
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Augmentation of anti-tumor effect of interleukin 2 with sizofiran in mice.
    Ikeuchi K
    Keio J Med; 1991 Sep; 40(3):132-8. PubMed ID: 1753556
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Natural cytotoxic reactivity of mouse lymphoid cells against syngeneic and allogeneic tumors. II. Characterization of effector cells.
    Herberman RB; Nunn ME; Holden HT; Lavrin DH
    Int J Cancer; 1975 Aug; 16(2):230-9. PubMed ID: 1080480
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Role of Corynebacterium parvum in the activation of peritoneal macrophages. II. Identification of distinguishable anti-tumor activities by macrophage subpopulations.
    Chapes SK; Haskill S
    Cell Immunol; 1983 Feb; 76(1):49-57. PubMed ID: 6219754
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Differences in the induction of macrophage cytotoxicity by the specific T lymphocyte factor, specific macrophage arming factor (SMAF), and the lymphokine, macrophage activating factor (MAF).
    De Groot JW; De Weger RA; Vandebriel RJ; Den Otter W
    Immunobiology; 1989 Jun; 179(2-3):131-44. PubMed ID: 2676851
    [TBL] [Abstract][Full Text] [Related]  

  • 20. LY-2+ effectors cytotoxic for syngeneic tumor cells: generation by allogeneic stimulation and by supernatants from mixed leukocyte cultures.
    Hurrell SM; Zarling JM
    J Immunol; 1983 Aug; 131(2):1017-23. PubMed ID: 6223084
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.